FOXO4 — Bespoke Biology
Cellular Renewal Peptide · Injectable · Longevity & Cellular

FOXO4

Your body is constantly replacing old, damaged cells with new, healthy ones. As you age, that process breaks down — damaged cells stop dying the way they should and start piling up in your tissues. FOXO4 is designed to fix that. It tells your damaged cells to finish their natural life cycle, clearing the way for your healthy cells to thrive.

The result is less inflammation, better tissue function, and a cellular environment that looks and behaves younger. It's one of the most targeted anti-aging compounds in research today.

Longevity & Cellular Cellular Renewal Injectable
Book a Consultation
At a Glance
Clears
Targets and removes damaged cells — leaves healthy tissue untouched
Precise
Targets the specific signal that keeps damaged cells alive when they should die
20 days
Short cycle · typically repeated every 4–6 months
Cell, 2017
Foundational research published in one of science's most respected journals
Enzyme-resistant design
Engineered to survive in the body long enough to reach and work inside your cells
Important
FOXO4 is not FDA-approved and has no completed human clinical trials as of 2026. It is available as a compounded injectable under provider supervision, based on preclinical and mechanistic research. This page is for educational purposes only. Consult a qualified healthcare provider before starting any protocol.
/

How FOXO4 Works

Every cell has a life cycle. Cells grow, do their job, and eventually wear out. When a healthy cell wears out, it's supposed to self-destruct — a clean, programmed process that makes room for new, healthy cells to take over. That process is called apoptosis, and it's one of the ways your body maintains itself.

Sometimes cells get stuck. When a cell is damaged — by age, stress, DNA errors, or toxin exposure — it can enter a kind of "zombie state" called senescence. A senescent cell stops doing its job, but it doesn't die. Instead, it sits in your tissues and constantly releases inflammatory signals that damage the healthy cells around it. Scientists call this the SASP — a cloud of chemical alarm signals that harms neighboring tissue and drives chronic inflammation throughout the body.

These zombie cells accumulate with age. When you're young, your immune system clears most of them quickly. As you get older, they pile up faster than your body can remove them. By middle age, this buildup is a meaningful driver of joint stiffness, brain fog, low energy, and nearly every major age-related disease.

FOXO4 removes the roadblock. Inside senescent cells, a protein called FOXO4 is essentially holding the "self-destruct" switch in the off position — keeping the cell alive when it should die. FOXO4 (the peptide) is engineered to bind to that switch, knock FOXO4 (the protein) out of the way, and let the cell's natural self-destruct signal do its job. The zombie cell dies. Healthy cells, which aren't using this survival trick, are unaffected.

Why doesn't the body just break it down? Most peptides — short protein fragments — are quickly destroyed by enzymes in the body before they can get where they need to go. FOXO4 is engineered with a "mirror image" molecular structure that the body's enzymes don't recognize. That means it survives long enough to enter your cells, reach its target, and do its job — rather than being broken down before it even gets there. This engineering is a big part of what makes it viable as a therapeutic.


/

What FOXO4 Does

Because damaged cells affect nearly every system in the body, clearing them has wide-ranging effects. These benefits are supported by preclinical and mechanistic research; human clinical trial data is not yet available.

Clears Damaged Cells — Spares Healthy Ones

FOXO4's most important quality is its precision. It targets only the survival signal active in damaged zombie cells — so when those cells die, the healthy tissue around them is untouched. This is what separates it from broad anti-inflammatory approaches, which mask the symptoms of aging without addressing the source.

Reduces Chronic Inflammation

Zombie cells are constantly releasing inflammatory signals into surrounding tissue. Clear the cells, and those signals stop. People often experience this as reduced joint stiffness, better recovery after activity, more consistent energy, and a general sense that the low-grade aching or fatigue they'd written off as "just getting older" has improved.

Supports Tissue & Organ Renewal

In research studies, mice treated with FOXO4 showed improved physical fitness, better kidney function, and even hair regrowth. The reason is straightforward: when the cells blocking normal tissue repair are removed, the surrounding healthy cells and stem cells can get back to doing what they're supposed to do — regenerating and maintaining the tissue around them.

Brain & Cognitive Function

Your brain is made up of cells just like every other organ — and those cells age, get damaged, and can get stuck in the same zombie state as cells anywhere else in the body. The brain is actually especially vulnerable to this, because brain cells that go senescent release inflammatory signals directly into neural tissue. That inflammation disrupts the communication between neurons, interferes with how memories are formed and retrieved, and over time contributes to the mental fogginess, slower processing, and cognitive decline many people experience as they age.

FOXO4 clears those stuck cells from brain tissue the same way it clears them elsewhere — which quiets the inflammation signal, gives healthy neurons a cleaner environment to operate in, and supports the brain's own repair mechanisms. People often describe this as sharper focus, faster recall, and a sense of mental clarity that had gradually faded. The research into FOXO4's specific effects on brain aging and neurodegeneration is ongoing and considered one of the most promising areas of senolytic science.

Heart & Blood Vessel Health

A 2025 study found that FOXO4 specifically clears damaged cells lining the blood vessels — the cells that govern circulation and cardiovascular function. As those cells age and become dysfunctional, blood vessel health declines. Removing them gives the vasculature a chance to restore normal function. Cardiovascular aging is closely tied to this type of cellular buildup.

Energy & Metabolic Function

Damaged cells are a drain — they consume cellular resources while producing nothing useful. As that burden decreases, the body's energy resources are freed up and redirected to healthy function. People commonly report improved energy levels and better physical capacity after FOXO4 protocols, as the body is no longer spending resources managing the inflammatory output of zombie cells.


/

The Research Behind FOXO4

FOXO4 has strong scientific backing and a clear, well-understood mechanism. The honest context: no human clinical trials have been completed as of 2026. The science is real and actively expanding — the human data is still being developed.

Foundational Study · Cell · 2017 · Baar et al.
The study that started it all — clearing zombie cells restored physical fitness and organ function in mice
The landmark 2017 paper published in Cell — one of the most respected scientific journals in the world — showed that treating aged mice with FOXO4 selectively cleared senescent cells and produced striking results: restored grip strength and running capacity, improved fur density, and better kidney function. Critically, healthy cells were not harmed. The precision and effectiveness of the results attracted widespread scientific attention and launched an entire field of senolytic research.
Structural Confirmation · Nature Communications · 2025
Scientists confirmed exactly how FOXO4 works at the atomic level
A 2025 paper in Nature Communications mapped out, at atomic resolution, precisely how FOXO4 binds to its target inside senescent cells — confirming that the mechanism proposed in 2017 is structurally accurate. Think of it as moving from a theory to a detailed blueprint. This kind of confirmation is significant: it validates the original science and gives researchers the foundation they need to design even more effective versions of the compound.
Vascular Health · Frontiers in Bioengineering · 2025
FOXO4 clears damaged cells in blood vessel linings — new cardiovascular application confirmed
A 2025 study tested FOXO4 specifically on the cells lining blood vessels — cells that are critically important for circulation and heart health. Under conditions that mimic the kind of stress these cells experience during aging, FOXO4 successfully cleared the damaged cells and improved overall endothelial function. This confirmed that FOXO4's effect extends beyond general tissue aging into cardiovascular health specifically — a meaningful finding given how central blood vessel function is to overall longevity.
Cleara Biotech · Clinical Translation
A biotech company was founded specifically to bring FOXO4 to human clinical trials
The 2017 Cell paper was compelling enough to attract serious investment capital. Cleara Biotech was founded and backed by Apollo Ventures specifically to translate FOXO4 from a research peptide into a validated medical treatment. The company is pursuing clinical development across multiple diseases where senescent cell buildup plays a role — including COPD, osteoarthritis, and kidney disease. The fact that a well-funded biotech is actively moving FOXO4 through the clinical pipeline reflects the strength of the underlying science.

Where the science stands. FOXO4's mechanism is well understood and its results in preclinical research are compelling. As of 2026, no human clinical trial has been completed. Compounded use is based on the strength of the preclinical evidence and mechanistic rationale — the same foundation used for many other compounded peptides in clinical practice. Your Bespoke Biology provider will assess whether FOXO4 is appropriate for your individual goals and health picture during your consultation.


/

Common Questions

What is a "zombie cell" and why does it matter?+
As cells age or get damaged, they're supposed to die cleanly so the body can replace them with new ones. Sometimes they don't — instead they enter a stuck state called senescence, where they stop working but refuse to die. These stuck cells (sometimes called "zombie cells" or senescent cells) sit in your tissues and release a constant stream of inflammatory signals that damage surrounding healthy cells. As you age, they pile up faster than your immune system can clear them. By middle age, this buildup is a real contributor to joint pain, low energy, brain fog, and accelerated aging across multiple organ systems.
How is this different from other anti-aging treatments?+
Most anti-aging approaches try to manage the symptoms of aging — reducing inflammation, replenishing hormones, protecting cells from further damage. FOXO4 takes a different approach: it removes the source of the problem. Instead of managing what zombie cells are doing, it clears them entirely — which reduces inflammation, allows healthy tissue to repair itself, and creates a cellular environment that supports better function across multiple systems at once.
How does it know which cells to clear?+
Damaged senescent cells use a specific survival signal — a protein interaction that keeps them alive when they should die. Healthy cells don't rely on that same signal. FOXO4 is designed to block that signal specifically, which triggers cell death in zombie cells while leaving normal, healthy cells unaffected. This built-in selectivity is what makes it so compelling scientifically — it addresses the problem without collateral damage to healthy tissue.
Why is it injected?+
FOXO4 needs to get inside your cells to work. When taken orally, peptides like this are broken down in the digestive tract before they reach the bloodstream — the same reason insulin can't be taken as a pill. Injection delivers FOXO4 directly into the bloodstream, where it can circulate and reach its targets. It's also engineered with a mirror-image molecular structure that makes it resistant to breakdown by the body's enzymes, extending the time it stays active.
Has it been tested in humans?+
Not yet in completed trials. FOXO4 has strong preclinical evidence — a landmark 2017 study in Cell, structural confirmation in Nature Communications (2025), and an active clinical development pipeline through Cleara Biotech. As of 2026, no completed human clinical trial has been published. Compounded use is based on the strength of the preclinical and mechanistic evidence, under provider supervision — the same framework used for many other compounded peptides in integrative and longevity medicine.
How does this fit with other Bespoke Biology protocols?+
FOXO4 clears out cellular debris that interferes with how other protocols work. Think of it as improving the environment your other therapies are operating in. Protocols like Epithalon (telomere support), NAD+ (cellular energy), MOTS-c (metabolic function), and Thymosin Alpha-1 (immune health) all work at the cellular level — they work better when the tissue around them isn't burdened with zombie cells putting out inflammatory signals. Your provider will assess the right timing and stacking for your goals.
Can FOXO4 help with brain fog or cognitive function?+
Potentially, yes — and the mechanism makes sense. Brain cells age and get damaged just like cells anywhere else in the body. When they enter the zombie state, they release inflammatory signals directly into neural tissue. That inflammation disrupts the way neurons communicate with each other, which affects memory, focus, processing speed, and mental clarity. It's one reason cognitive decline tends to creep in gradually — the inflammatory burden builds slowly over years.

FOXO4 clears those stuck cells from brain tissue, quieting the inflammatory signal and giving healthy neurons a cleaner environment to work in. The brain also has its own stem cell populations that help maintain and repair neural tissue — and those work better when they're not surrounded by cells putting out damage signals. People often describe sharper focus, faster recall, and a return of mental clarity that had gradually faded as part of their overall response to a FOXO4 protocol. The research on FOXO4's effects on brain aging is one of the most actively studied areas in senolytic science right now.
What should I expect side-effect wise?+
FOXO4 is generally well tolerated. The most common effects show up in the first week and reflect the clearance process itself — a temporary flu-like feeling or fatigue as the body processes the cleared cells, and mild redness or swelling at the injection site. These effects are considered signs the compound is working, not traditional adverse reactions. Mild nausea is occasionally reported but resolves quickly. Allergic reactions are rare. Reach out to your provider if anything feels significant or doesn't resolve within the first two weeks.
How do I store it?+
Refrigerate at 36–46°F (2–8°C). Do not freeze. Protect from light and heat. Do not shake the vial vigorously. Write the date of first use on the label and use within 28–30 days of opening. Do not use if the liquid appears cloudy or discolored — contact your provider.

/

Side Effects to Watch For

  • /Temporary fatigue or flu-like feeling — common in week 1 as the body processes cleared cells; a sign the protocol is working
  • /Injection site redness or swelling — rotate injection sites to prevent buildup at any one spot
  • /Mild nausea — rare, resolves quickly
  • /Allergic reaction — rare; stop use and seek medical care immediately if you notice rash, swelling, or difficulty breathing

The flu-like symptoms in week one are expected and generally considered a sign that the clearance process is active. Contact your provider if anything feels significant or doesn't resolve within the first two weeks.

Ready to begin

Learn More About FOXO4

USA-formulated, lab-verified formula. Protocol guidance provided during your complimentary consultation with a Bespoke Biology provider.

Book a Consultation

515 E Las Olas Boulevard

Suite 1301-L32

Fort Lauderdale, FL 33301

728-300-6020

[email protected]

For educational purposes only. Many compounds referenced on this site are investigational and not FDA-approved.
Always consult a qualified healthcare provider before starting any peptide regimen.

© 2026 Bespoke Biology